A new drug just cleared hepatitis B in 1 in 5 patients

BY THE OPTIMIST DAILY EDITORIAL TEAM

A clinical trial published May 28 in the New England Journal of Medicine reports that a new drug called bepirovirsen achieved a functional cure in approximately one in five patients with chronic hepatitis B.

That number matters. The current standard of care…

Click here to view the original article.